Salomon & Ludwin’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$37.1K Buy
2,705
+320
+13% +$4.36K ﹤0.01% 602
2026
Q2
$32.3K Buy
2,385
+1,633
+217% +$19.5K ﹤0.01% 797
2026
Q1
$4.78K Sell
752
-977
-57% -$7.35K ﹤0.01% 1771
2025
Q4
$12.9K Sell
1,729
-172
-9% -$1.36K ﹤0.01% 1265
2025
Q3
$20.9K Buy
1,901
+1,799
+1,764% +$17.7K ﹤0.01% 780
2025
Q2
$1.04K Hold
102
– – ﹤0.01% 739
2025
Q1
$1.52K Hold
102
– – ﹤0.01% 607
2024
Q4
$1.52K Sell
102
-7
-6% -$114 ﹤0.01% 621
2024
Q3
$2.08K Sell
109
-32
-23% -$663 ﹤0.01% 609
2024
Q2
$2.92K Sell
141
-166
-54% -$3.3K ﹤0.01% 575
2024
Q1
$5.77K Sell
307
-213
-41% -$3.66K ﹤0.01% 616
2023
Q4
$9.03K Hold
520
– – ﹤0.01% 508
2023
Q3
$9.03K Buy
+520
New +$10.8K ﹤0.01% 506

Other funds holding OGN

Salomon & Ludwin's OGN Position: Q3 2026 in Review

Salomon & Ludwin increased its Organon & Co (OGN) stake by 13% in Q3 2026, buying an estimated $4.36K and bringing the position to 2,705 shares worth $37.1K. The position accounts for ﹤0.01% of the portfolio, ranked #602.

Salomon & Ludwin first reported a position in OGN in Q3 2023 and has held it in 13 quarters since. 319 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Salomon & Ludwin held 2,705 shares of Organon & Co worth $37.1K as of Q3 2026.
  • Salomon & Ludwin bought 320 Organon & Co shares in Q3 2026, an estimated $4.36K.
  • Organon & Co made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #602 holding.
  • Salomon & Ludwin first reported a position in Organon & Co in Q3 2023 and has held it in 13 quarters since.
  • 319 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.